Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-05-08
2007-05-08
Foley, Shanon (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387700
Reexamination Certificate
active
11126176
ABSTRACT:
The invention relates to a method for controlling the activity of an immunologically functional molecules, such as an antibody, a protein, a peptide or the like, an agent of promoting the activity of an immunologically functional molecule, and an immunologically functional molecule having promoted activity.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly
patent: 5453363 (1995-09-01), Rudolph
patent: 5728568 (1998-03-01), Sullivan
patent: 5858983 (1999-01-01), Seed et al.
patent: 6054304 (2000-04-01), Taniguchi et al.
patent: 6602684 (2003-08-01), Umana et al.
patent: 6946292 (2005-09-01), Kanda et al.
patent: 2003/0157108 (2003-08-01), Presta
patent: 2004/0072290 (2004-04-01), Umana et al.
patent: 2005/0226867 (2005-10-01), Iida et al.
patent: 2005/0262593 (2005-11-01), Kanda et al.
patent: 2005/0272916 (2005-12-01), Hanai et al.
patent: 2005/0276805 (2005-12-01), Hanai et al.
patent: 2005/0287138 (2005-12-01), Iida et al.
patent: 2006/0024800 (2006-02-01), Hanai et al.
patent: 2006/0063254 (2006-03-01), Kanda et al.
patent: 2006/0064781 (2006-03-01), Kanda et al.
patent: 2006/0078990 (2006-04-01), Kanda et al.
patent: 2006/0078991 (2006-04-01), Kanda et al.
patent: 623352 (1994-11-01), None
patent: 882794 (1998-09-01), None
patent: 1 176 195 (2002-01-01), None
patent: WO 91/19501 (1991-12-01), None
patent: WO 94/16094 (1994-07-01), None
patent: 97/27303 (1997-07-01), None
patent: 97/30087 (1997-08-01), None
patent: 97/37683 (1997-10-01), None
patent: 98/54964 (1998-12-01), None
patent: 99/54342 (1999-10-01), None
patent: WO 99/54342 (1999-10-01), None
patent: 99/64618 (1999-12-01), None
patent: 00/61739 (2000-10-01), None
patent: WO 03/035835 (2003-05-01), None
Shitara et al (Journal of Immunological Methods 167:271-278, 1994, IDS).
Jensen et al (Ann Hematol, 1998, 77:89-91).
Genentech (Products—product Information—Facts About RITUXAN, p. 1-3.
Reff et al (Blood, 1994, 83:435-445).
Shinkawa et al (J of Biological Chemistry, 2003, 278:3466-3473, IDS).
Shinkawa et al,The Journal of Biological Chemistry, 278, 3466-3473 (2003).
Ohyama et al, The Journal of Biological Chemistry, 1998, vol. 273, No. 23, pp. 14582-14587.
Sullivan et al, The Journal of Biological Chemistry, 1998, vol. 273, No. 14, pp. 8193-8202.
Ripka et al, Archives of Biochemistry and Biophysics, 1986, vol. 249, No. 2, pp. 533-545.
Ripka et al, Somatic Cell and Molecular Genetics, 1986, vol. 12, No. 1 pp. 51-62.
Shields et al, The Journal of Biological Chemistry, 2002, vol. 277, No. 30, pp. 26733-26740.
Routier et al (Glycoconjugate Journal 14:201-207 (1997).
U.S. Appl. No. 60/337,642, filed Oct. 2001, Presta.
U.S. Appl. No. 60/347,694, filed Jan. 2002, Presta.
U.S. Appl. No. 60/082,581, filed Apr. 1998, Umana et al.
Shitara et al, “A new vector for the high level expression of chimeric antibodies in myeloma cells”, Journal of Immunological Methods 167(1-2):271-278 (1994).
Wilson et al, “Structural analysis of N-glycans from allergenic grass, ragweed and tree pollens: Core α1, 3-linked fucose and xylose present in all pollens examined”, Glycoconjugate Journal 15(11):1055-1070 (1998).
Lifely et al, Glycobiology, 1995, vol. 5, No. 8, pp. 813-822.
Boyd et al, Molecular Immunology, 1995, vol. 32, No. 17/18, pp. 1311-1318.
Clark, Chem. Immunol. 1997, vol. 65, pp. 88-110.
Shinkawa et al, The Journal of Biological Chemistry, 2003, vol. 278, No. 5, pp. 3466-3473.
Jefferis et al (Biochem J. 268:529-537 (1990).
Furukawa et al Protein, Nucleic Acid and Enzyme, 43, 2309-2317 (1998).
Maly et al, Cell, vol. 86, 643-653, Aug. 23, 1996.
Wright et al. Tibtech, 15, 26-32 (1997).
Breton et al, Glycobiology, 8, No. 1, 87-94 (1998).
Asano et al, The EMBO Journal, vol. 16, No. 8, pp. 1850-1857 (1997).
Shitara et al. Journal of Immunological Methods, 167, 271-278 (1994).
Oriol et al. Glycobiology, 9, No. 4, 323-334 (1999).
Raju, et al. (2000) Glycobiology, 10(5): 477-86.
Stryer (1988) Biochemistry, 3rd Ed., Freeman and Co., New York, NY, pp. 35-37.
Shinkawa, et al. (2003) J. Biol. Chem., 278(5): 3466-73.
Jones, et al. (2001) Pharmacogenomics J., 1(2): 126-34.
Lifely, et al. (1995) Glycobiology, 5(8): 813-22.
U.S. Appl. No. 11/279,748, filed Apr. 2006, Kanda et al.
U.S. Appl. No. 09/958,307, filed Oct. 2001, Kanda et al.
Wilson et al, “Structural analysis of N-glycans from allergenic grass, ragweed and tree pollens: Core 1, 3-linked fucose and xylose present in all pollens examined”, Glycoconjugate Journal 15(11):1055-1070 (1998).
Jefferies et al (BioChem J. 268 :529-537 (1990).
Routier et al (Glycoconjugate Journal 14 :201-207 (1997)).
Potellignent™ Technology, BioWa, Inc, internet address: biowa.com
ews/pdf/Bio2003%20&%20Anti-Cancer%20BioWa%20Non%20Confidential.pdf#search=22Potelligent%20Technology%20BioWa%2C%20Inc.%20pdf% 22, Jul. 21, 2004.
Yamane-Ohnuki et al, Biotechnology % Bioengineering, vol. 87, No. 5, Sep. 5, 2004.
Rituxan product insert, 2 pages, © 2004 IDEC Pharmaceuticals Corporation and Genentech Inc.
Nose, J Immunology (1990) vol. 145, No. 3, 910-914.
Anazawa Hideharu
Hanai Nobuo
Hosaka Emi
Imabeppu Susumu
Kanda Yutaka
Foley Shanon
Goddard Laura B
Kyowa Hakko Kogyo Co. Ltd.
Nixon & Vanderhye P.C.
LandOfFree
Method of modulating the activity of functional immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of modulating the activity of functional immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of modulating the activity of functional immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816056